TABLE 1.
Class | HDAC family | Localization | Major target molecular | Function to cardiac hypertrophy | Other effects | References |
I | HDAC1 | Nucleus | Mef2C | Promote | Cell proliferation, differentiation, development, cancer | (136) |
HDAC2 | Nucleus | Inpp5f | Promote | Cell proliferation, development, synaptic plasticity, differentiation | (6, 51) | |
HDAC3 | Nucleus/Cytoplasm | Mef2C | Inhibit | Cell proliferation, development | (54) | |
HDAC8 | Nucleus | p38 | Promote | Smooth muscle differentiation and contractility | (137) | |
IIa | HDAC4 | Nucleus/Cytoplasm | Mef2C | Inhibit | Bone development, neuron development | (53) |
HDAC5 | Nucleus/Cytoplasm | Mef2C | Inhibit | Bone development, axonal regeneration | (57) | |
HDAC7 | Nucleus/Cytoplasm | c-Myc | Promote | Vascular development, immunomodulation | (138) | |
HDAC9 | Nucleus/Cytoplasm | Mef2C | Inhibit | Neuron development, synaptic plasticity, immunomodulation | (139) | |
IIb | HDAC6 | Cytoplasm | α-tubulin | Promote | Cytoskeletal dynamics, cell motility, aggresome formation, autophagy | (140) |
HDAC10 | Nucleus/Cytoplasm | pRb | − | Cell cycle, immunomodulation, cancer | ||
III | SIRT1 | Nucleus | PGC-1α | Inhibit | Cell survival, aging, energy metabolism, inflammation | (78) |
SIRT2 | Nucleus | LKB1 | Inhibit | Microtubule stability | (85) | |
SIRT3 | Cytoplasm | FoxO3a | Inhibit | Energy metabolism | (80) | |
SIRT4 | Cytoplasm | Sirt3 | Promote | Energy metabolism | (141) | |
SIRT5 | Cytoplasm | ECHA | Inhibit | Urea cycle, apoptosis, energy metabolism | (142) | |
SIRT6 | Nucleus | NFATc4 | Inhibit | Telomeric DNA redulation | (86) | |
SIRT7 | Nucleus | Histone 3 | − | Apoptosis | ||
IV | HDAC11 | Nucleus/Cytoplasm | Promote | Immunomodulation, energy metabolism | (143, 144) |
ECHA, enoyl-coenzyme A hydratase; FoxO3, Forkhead box O3; Inpp5f, inositol-5 phosphatase f; NFATc4, nuclear factor of activated T-cells; PGC-1α, Peroxisome proliferator-activated receptor gamma coactivator-1 alpha.